BU Team Developing Microfluidic Chip for Point-of-Care Using Helicase-Dependent Amplification | GenomeWeb

By Bernadette Toner

A team of researchers at Boston University is developing a microfluidic chip using a PCR alternative, claiming it could serve as the basis for low-cost, handheld molecular diagnostics for use in global health environments.

The key to the system is helicase-dependent amplification, an isothermal amplification method that is similar to PCR in many ways but does not require a thermal cycler, and is therefore more suitable for in-field use.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.